{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:40Z","timestamp":1790334820385,"version":"4.1.0"},"reference-count":318,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This evidence\u2010 and consensus\u2010based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clinical and comorbid situations such as treating psoriasis vulgaris patient with concomitant psoriatic arthritis, concomitant inflammatory bowel disease, a history of malignancies or a history of depression or suicidal ideation. It further holds recommendations for concomitant diabetes, viral hepatitis, disease affecting the heart or the kidneys as well as concomitant neurological disease. Advice on how to screen for tuberculosis and recommendations on how to manage patients with a positive tuberculosis test result are given. It further covers treatment for pregnant women or patients with a wish for a child in the near future. Information on vaccination, immunogenicity and systemic treatment during the COVID\u201019 pandemic is also provided.<\/jats:p>","DOI":"10.1111\/jdv.16926","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T12:37:27Z","timestamp":1612787847000},"page":"281-317","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":223,"title":["EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris \u2013 Part 2: specific clinical and comorbid situations"],"prefix":"10.1111","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3504-2203","authenticated-orcid":false,"given":"A.","family":"Nast","sequence":"first","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin Corporate Member of Freie Universit\u00e4t Berlin Department of Dermatology, Venereology and Allergology Humboldt\u2010Universit\u00e4t zu Berlin, and Berlin Institute of Health Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.I.","family":"Spuls","sequence":"additional","affiliation":[{"name":"Academic Medical Centre Amsterdam Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Avila Valle","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin Corporate Member of Freie Universit\u00e4t Berlin Department of Dermatology, Venereology and Allergology Humboldt\u2010Universit\u00e4t zu Berlin, and Berlin Institute of Health Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Bata\u2010Cs\u00f6rg\u00f6","sequence":"additional","affiliation":[{"name":"University of Szeged Szeged Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Boonen","sequence":"additional","affiliation":[{"name":"Office\u2010Based Dermatology Practice Geel Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"De Jong","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre Nijmegen Nijmegen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Garcia\u2010Doval","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n. Fundaci\u00f3n Piel Sana AEDV Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gisondi","sequence":"additional","affiliation":[{"name":"University of Verona Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kaur\u2010Knudsen","sequence":"additional","affiliation":[{"name":"University Hospital Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mahil","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' NHS Foundation Trust London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"M\u00e4lk\u00f6nen","sequence":"additional","affiliation":[{"name":"Helsinki University Central Hospital Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Maul","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of Z\u00fcrich Z\u00fcrich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mburu","sequence":"additional","affiliation":[{"name":"International Federation of Psoriasis Associations (IFPA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mrowietz","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Schleswig\u2010Holstein Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Reich","sequence":"additional","affiliation":[{"name":"Translational Research in Inflammatory Skin Diseases Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg\u2010Eppendorf Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Remenyik","sequence":"additional","affiliation":[{"name":"University of Debrecen Debrecen Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"R\u00f8nholt","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Sator","sequence":"additional","affiliation":[{"name":"Municipal Hospital Hietzing Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmitt\u2010Egenolf","sequence":"additional","affiliation":[{"name":"Dermatology Department of Public Health &amp; Clinical Medicine Ume\u00e5 University Ume\u00e5 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sikora","sequence":"additional","affiliation":[{"name":"Department of Dermatology Medical University of Warsaw Warsaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Str\u00f6mer","sequence":"additional","affiliation":[{"name":"Office\u2010Based Dermatology Practice M\u00f6nchengladbach Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sundnes","sequence":"additional","affiliation":[{"name":"Oslo University Hospital Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Trigos","sequence":"additional","affiliation":[{"name":"International Federation of Psoriasis Associations (IFPA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Van Der Kraaij","sequence":"additional","affiliation":[{"name":"Academic Medical Centre Amsterdam Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yawalkar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Inselspital Bern University Hospital University of Bern Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dressler","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin Corporate Member of Freie Universit\u00e4t Berlin Department of Dermatology, Venereology and Allergology Humboldt\u2010Universit\u00e4t zu Berlin, and Berlin Institute of Health Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.011"},{"key":"e_1_2_5_4_1","unstructured":"The GRADE Working Group. In Vol. 2018.2018."},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13995"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13957"},{"key":"e_1_2_5_7_1","first-page":"Cd011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta\u2010analysis","volume":"1","author":"Sbidian E","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13354"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14454"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0898-2"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2018-0075"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215386"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-018-0106-6"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15482"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105924"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200350"},{"key":"e_1_2_5_17_1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ddg.13538","article-title":"S3 Guideline for the treatment of psoriasis vulgaris, update \u2010 Short version part 2 \u2010 Special patient populations and treatment situations","volume":"16","author":"Nast A","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15340"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.058"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09593.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0770"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.298"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00340-3"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1882-2"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30570-6"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31773-8"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.043"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30233-4"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy099"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz033"},{"key":"e_1_2_5_32_1","first-page":"1","article-title":"Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease","author":"Berman HS","year":"2019","journal-title":"J Dermatol Treat"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx180.004"},{"key":"e_1_2_5_34_1","first-page":"Cd006884","article-title":"Methotrexate for maintenance of remission in Crohn's disease","volume":"2014","author":"Patel V","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_35_1","first-page":"Cd003459","article-title":"Methotrexate for induction of remission in refractory Crohn's disease","volume":"2014","author":"McDonald JW","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_36_1","first-page":"Cd006618","article-title":"Methotrexate for induction of remission in ulcerative colitis","volume":"2014","author":"Chande N","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1098","key":"e_1_2_5_37_1","first-page":"e9","article-title":"Methotrexate is not superior to placebo in maintaining steroid\u2010free response or remission in ulcerative colitis","volume":"155","author":"Herfarth H","year":"2018","journal-title":"Gastroenterology"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14072"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313060"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.037"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0024"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15830"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14776"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key208"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.05.009"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39689"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201814"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000865"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3029"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.03.037"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3605"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17208"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12909"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3114"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2015.04.008"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1467536"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15012"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1159\/000479163"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1541-7"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1466021"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.051"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01447.x"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6678.964"},{"key":"e_1_2_5_64_1","first-page":"409","article-title":"Depression and acitretin: a true association or a class labeling?","volume":"10","author":"Hayes J","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_65_1","first-page":"690","article-title":"Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects","volume":"4","author":"Starling J","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_66_1","unstructured":"European Medicines Agency. Retinoid\u2010containing medicinal products. In.2018."},{"key":"e_1_2_5_67_1","unstructured":"European Medicines Agency.Acitretin SmPC and Patient Leaflet. In: The electronic medicines compendium. Last updated 22 0ct 2019."},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1579794"},{"key":"e_1_2_5_71_1","unstructured":"European Medicines Agency.Kyntheum SmPC and Patient Leaflet. In: The electronic medicines compendium. Last updated 25 sep 2017."},{"issue":"310","key":"e_1_2_5_72_1","first-page":"e1","article-title":"Long\u2010term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for >\/=156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)","volume":"77","author":"Crowley J","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1901-3"},{"key":"e_1_2_5_74_1","unstructured":"European Medicines Agency.Otezla (apremilast): New important advice regarding suicidal ideation and behaviour. In: Celgene Europe Limited.2016."},{"key":"e_1_2_5_75_1","unstructured":"European Medicines Agency.Otezla SmPC and Patient Leaflet. In: The electronic medicines compendium. Last updated 10 Sep 2019."},{"key":"e_1_2_5_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamadermatol.406"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.01.009"},{"key":"e_1_2_5_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12473"},{"key":"e_1_2_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.11.023"},{"key":"e_1_2_5_80_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009990"},{"key":"e_1_2_5_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26"},{"key":"e_1_2_5_82_1","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2019.7965"},{"key":"e_1_2_5_83_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.71358"},{"key":"e_1_2_5_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12296"},{"key":"e_1_2_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.01.024"},{"key":"e_1_2_5_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23789"},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04450.x"},{"key":"e_1_2_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2013.03.009"},{"key":"e_1_2_5_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000084295.67371.11"},{"key":"e_1_2_5_90_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2011.1548"},{"key":"e_1_2_5_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02429.x"},{"key":"e_1_2_5_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2011.01439.x"},{"key":"e_1_2_5_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12235"},{"key":"e_1_2_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.057"},{"key":"e_1_2_5_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2010.05.003"},{"key":"e_1_2_5_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2369-1"},{"key":"e_1_2_5_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0784-3"},{"key":"e_1_2_5_98_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.1753"},{"key":"e_1_2_5_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0678-9"},{"key":"e_1_2_5_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200702000408"},{"key":"e_1_2_5_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12814"},{"key":"e_1_2_5_102_1","first-page":"235","article-title":"Effects of tumor necrosis factor alpha inhibitors extend beyond psoriasis: insulin sensitivity in psoriasis patients with type 2 diabetes mellitus","volume":"97","author":"Al\u2010Mutairi N","year":"2016","journal-title":"Cutis"},{"key":"e_1_2_5_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16004"},{"key":"e_1_2_5_104_1","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate\u2010to\u2010severe chronic plaque psoriasis to low\u2010dose cyclosporine therapy: a randomized, controlled, investigator\u2010blinded clinical trial","volume":"88","author":"Gisondi P","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_5_105_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.722"},{"key":"e_1_2_5_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12735"},{"key":"e_1_2_5_107_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.1412"},{"key":"e_1_2_5_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1626973"},{"key":"e_1_2_5_109_1","unstructured":"KoenigAS SzumskiA PedersenR RobertsonD.Impact of Etanercept Therapy on Glycemical Control in a Cohort of Psoriatic Patients: The PRISTINE Trial. In.2010."},{"key":"e_1_2_5_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-014-0156-6"},{"key":"e_1_2_5_111_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.19902071.x"},{"key":"e_1_2_5_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12875"},{"key":"e_1_2_5_113_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"e_1_2_5_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"e_1_2_5_115_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"e_1_2_5_116_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101124"},{"key":"e_1_2_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.035"},{"key":"e_1_2_5_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.321"},{"key":"e_1_2_5_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.399"},{"key":"e_1_2_5_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.149"},{"key":"e_1_2_5_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.01.197"},{"key":"e_1_2_5_122_1","doi-asserted-by":"publisher","DOI":"10.1159\/000502138"},{"key":"e_1_2_5_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.103"},{"key":"e_1_2_5_124_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.7.284"},{"key":"e_1_2_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(81)70057-4"},{"key":"e_1_2_5_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.09.020"},{"key":"e_1_2_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70359-2"},{"key":"e_1_2_5_128_1","first-page":"CD007893","article-title":"Effect of cyclosporine on blood pressure","volume":"2010","author":"Robert N","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08213-2"},{"key":"e_1_2_5_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.06.017"},{"key":"e_1_2_5_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep366"},{"key":"e_1_2_5_132_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"e_1_2_5_133_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12768"},{"key":"e_1_2_5_134_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14841"},{"key":"e_1_2_5_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2018.03.009"},{"key":"e_1_2_5_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114207"},{"key":"e_1_2_5_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08628.x"},{"key":"e_1_2_5_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12118"},{"key":"e_1_2_5_139_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40366"},{"key":"e_1_2_5_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.679"},{"key":"e_1_2_5_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0147-y"},{"key":"e_1_2_5_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.131359"},{"key":"e_1_2_5_143_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13398"},{"key":"e_1_2_5_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.042"},{"key":"e_1_2_5_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10525.x"},{"key":"e_1_2_5_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15021"},{"key":"e_1_2_5_147_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1211"},{"key":"e_1_2_5_148_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.2502"},{"key":"e_1_2_5_149_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2012.02593.x"},{"key":"e_1_2_5_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.042"},{"key":"e_1_2_5_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10257.x"},{"key":"e_1_2_5_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12214"},{"key":"e_1_2_5_153_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14964"},{"key":"e_1_2_5_154_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000763"},{"key":"e_1_2_5_155_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16018"},{"key":"e_1_2_5_156_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0001"},{"key":"e_1_2_5_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2016.11.005"},{"key":"e_1_2_5_158_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116834"},{"key":"e_1_2_5_159_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-199905000-00003"},{"key":"e_1_2_5_160_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.25.3224"},{"key":"e_1_2_5_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(02)00121-6"},{"key":"e_1_2_5_162_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"e_1_2_5_163_1","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta\u2010analysis and Cochrane overview","volume":"2011","author":"Singh JA","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_164_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5961"},{"key":"e_1_2_5_165_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.2768"},{"key":"e_1_2_5_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09755.x"},{"key":"e_1_2_5_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.03.027"},{"key":"e_1_2_5_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2013.01.003"},{"key":"e_1_2_5_169_1","first-page":"CD005414","article-title":"Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology","volume":"4","author":"Bath\u2010Hextall F","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_170_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb05369.x"},{"key":"e_1_2_5_171_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1076794"},{"key":"e_1_2_5_172_1","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4808-668"},{"key":"e_1_2_5_173_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1061-4"},{"key":"e_1_2_5_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.197"},{"key":"e_1_2_5_175_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.03992.x"},{"key":"e_1_2_5_176_1","doi-asserted-by":"publisher","DOI":"10.1159\/000351648"},{"key":"e_1_2_5_177_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2011.01559.x"},{"key":"e_1_2_5_178_1","first-page":"38","article-title":"Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy","volume":"22","author":"Kremer JM","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_5_179_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.57.2.110"},{"key":"e_1_2_5_180_1","first-page":"218","article-title":"The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis","volume":"22","author":"Rheumatoid Arthritis Clinical Trial Archive Group","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_5_181_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1608-3"},{"key":"e_1_2_5_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.08.001"},{"key":"e_1_2_5_183_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2000.tb01004.x"},{"key":"e_1_2_5_184_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101313240501"},{"key":"e_1_2_5_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2006.02.005"},{"key":"e_1_2_5_186_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12324"},{"key":"e_1_2_5_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91556-3"},{"key":"e_1_2_5_188_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013509232"},{"key":"e_1_2_5_189_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1215357"},{"key":"e_1_2_5_190_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1211805"},{"key":"e_1_2_5_191_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7311-1"},{"key":"e_1_2_5_192_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1300283"},{"key":"e_1_2_5_193_1","first-page":"1081","article-title":"Case reports of PML in patients treated for psoriasis","volume":"369","author":"Buttmann M","year":"2013","journal-title":"N Engl J Med"},{"key":"e_1_2_5_194_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24471"},{"key":"e_1_2_5_195_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413724"},{"key":"e_1_2_5_196_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0363-8"},{"key":"e_1_2_5_197_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000085"},{"key":"e_1_2_5_198_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2191"},{"key":"e_1_2_5_199_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740801908001"},{"key":"e_1_2_5_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.09.002"},{"key":"e_1_2_5_201_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1531"},{"key":"e_1_2_5_202_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11307"},{"key":"e_1_2_5_203_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2012.660520"},{"key":"e_1_2_5_204_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.1"},{"key":"e_1_2_5_205_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204195"},{"key":"e_1_2_5_206_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8238-5"},{"key":"e_1_2_5_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.01.023"},{"key":"e_1_2_5_208_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr237"},{"key":"e_1_2_5_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.08.029"},{"key":"e_1_2_5_210_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13412"},{"key":"e_1_2_5_211_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2015.2558"},{"key":"e_1_2_5_212_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-015-0027-z"},{"key":"e_1_2_5_213_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2419-8"},{"key":"e_1_2_5_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.08.047"},{"key":"e_1_2_5_215_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227584"},{"key":"e_1_2_5_216_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2015.12.017"},{"key":"e_1_2_5_217_1","doi-asserted-by":"publisher","DOI":"10.1159\/000485499"},{"key":"e_1_2_5_218_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.111500"},{"key":"e_1_2_5_219_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204575"},{"key":"e_1_2_5_220_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.11"},{"key":"e_1_2_5_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.004"},{"key":"e_1_2_5_222_1","first-page":"324","article-title":"[A case of Crohn's disease complicated by Guillain\u2010Barre syndrome during ustekinumab therapy]","volume":"116","author":"Fukushima T","year":"2019","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"e_1_2_5_223_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13224"},{"key":"e_1_2_5_224_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.161"},{"key":"e_1_2_5_225_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160307144027"},{"key":"e_1_2_5_226_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8128-x"},{"key":"e_1_2_5_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.03.009"},{"key":"e_1_2_5_228_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14619"},{"key":"e_1_2_5_229_1","first-page":"e110","article-title":"Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini\u2010review with a representative case report","volume":"34","author":"Venturini M","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_5_230_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.08.006"},{"key":"e_1_2_5_231_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612253152603"},{"key":"e_1_2_5_232_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.09.012"},{"key":"e_1_2_5_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.004"},{"key":"e_1_2_5_234_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw778"},{"key":"e_1_2_5_235_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08457.x"},{"key":"e_1_2_5_236_1","doi-asserted-by":"publisher","DOI":"10.1086\/429998"},{"key":"e_1_2_5_237_1","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018"},{"key":"e_1_2_5_238_1","first-page":"1761","article-title":"Extrapulmonary tuberculosis: an overview","volume":"72","author":"Golden MP","year":"2005","journal-title":"Am Family Phys"},{"key":"e_1_2_5_239_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197409000-00004"},{"key":"e_1_2_5_240_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90279-0"},{"key":"e_1_2_5_241_1","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control","author":"National Collaborating Centre for Chronic C, Centre for Clinical Practice at, Nice","year":"2011"},{"key":"e_1_2_5_242_1","first-page":"325","article-title":"Tuberculosis Guideline for Adults \u2010 Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)","volume":"71","author":"Schaberg T","year":"2017","journal-title":"Pneumologie (Stuttgart, Germany)"},{"key":"e_1_2_5_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.03.023"},{"key":"e_1_2_5_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.03.018"},{"key":"e_1_2_5_245_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8909834"},{"key":"e_1_2_5_246_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00432-y"},{"key":"e_1_2_5_247_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.056"},{"key":"e_1_2_5_248_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy174"},{"key":"e_1_2_5_249_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.849236"},{"key":"e_1_2_5_250_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1612872"},{"key":"e_1_2_5_251_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.052"},{"key":"e_1_2_5_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.12.025"},{"key":"e_1_2_5_253_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140102"},{"issue":"2","key":"e_1_2_5_254_1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.cmi.2018.02.002","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)","volume":"24","author":"Winthrop KL","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"e_1_2_5_255_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15653"},{"key":"e_1_2_5_256_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.024"},{"key":"e_1_2_5_257_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31713-6"},{"key":"e_1_2_5_258_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1996.tb01632.x"},{"key":"e_1_2_5_259_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.5.601"},{"key":"e_1_2_5_260_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14547"},{"key":"e_1_2_5_261_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.02.005"},{"key":"e_1_2_5_262_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.271"},{"key":"e_1_2_5_263_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09899.x"},{"key":"e_1_2_5_264_1","unstructured":"European Medicines Agency.Acitretin 25mg Capsules \u2010 Summary of Product Characteristics (SmPC) \u2010 (emc). In."},{"key":"e_1_2_5_265_1","unstructured":"European Medicines Agency.Otezla 30 mg Film\u2010Coated Tablets \u2010 Summary of Product Characteristics (SmPC) \u2010 (emc). In."},{"key":"e_1_2_5_266_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12641"},{"key":"e_1_2_5_267_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1525293"},{"key":"e_1_2_5_268_1","unstructured":"European Medicines Agency.Neoral Soft Gelatin Capsules \u2010 Summary of Product Characteristics (SmPC) \u2010 (emc). In."},{"key":"e_1_2_5_269_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17198"},{"key":"e_1_2_5_270_1","unstructured":"European Medicines Agency.Skilarence 30 mg Gastro\u2010resistant Tablets \u2010 Summary of Product Characteristics (SmPC) \u2010 (emc). In."},{"key":"e_1_2_5_271_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15218"},{"key":"e_1_2_5_272_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2019.05.066"},{"key":"e_1_2_5_273_1","unstructured":"European Medicines Agency.Methotrexate 2.5mg Tablets \u2010 Summary of Product Characteristics (SmPC) \u2010 (emc). In."},{"key":"e_1_2_5_274_1","unstructured":"European Medicines Agency.Nordimet \u2010 EPAR.2016."},{"key":"e_1_2_5_275_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14816"},{"key":"e_1_2_5_276_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15665"},{"key":"e_1_2_5_277_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.71"},{"key":"e_1_2_5_278_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00172.x"},{"key":"e_1_2_5_279_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15802"},{"key":"e_1_2_5_280_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.851666"},{"key":"e_1_2_5_281_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.11.011"},{"key":"e_1_2_5_282_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212196"},{"key":"e_1_2_5_283_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211384"},{"key":"e_1_2_5_284_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4261"},{"key":"e_1_2_5_285_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209322"},{"key":"e_1_2_5_286_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1208269"},{"key":"e_1_2_5_287_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.08.039"},{"key":"e_1_2_5_288_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0176-7"},{"key":"e_1_2_5_289_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.430"},{"key":"e_1_2_5_290_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38262"},{"key":"e_1_2_5_291_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12642"},{"key":"e_1_2_5_292_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2013.11.004"},{"key":"e_1_2_5_293_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21583"},{"key":"e_1_2_5_294_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12833"},{"key":"e_1_2_5_295_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.140822"},{"key":"e_1_2_5_296_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40508"},{"key":"e_1_2_5_297_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0272.1990.tb02034.x"},{"key":"e_1_2_5_298_1","doi-asserted-by":"publisher","DOI":"10.1159\/000063893"},{"key":"e_1_2_5_299_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.07.011"},{"key":"e_1_2_5_300_1","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12366"},{"key":"e_1_2_5_301_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.030"},{"key":"e_1_2_5_302_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01925.x"},{"key":"e_1_2_5_303_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640260091025"},{"key":"e_1_2_5_304_1","doi-asserted-by":"publisher","DOI":"10.3109\/01485017908985067"},{"key":"e_1_2_5_305_1","doi-asserted-by":"publisher","DOI":"10.1159\/000251036"},{"key":"e_1_2_5_306_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001936"},{"key":"e_1_2_5_307_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2017.10.004"},{"key":"e_1_2_5_308_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2017.08.013"},{"key":"e_1_2_5_309_1","first-page":"765","article-title":"Impact of TNF\u2010blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF\u2010blocking agents at time of conception","volume":"30","author":"Puchner R","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_310_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-019-02905-1"},{"key":"e_1_2_5_311_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418811335"},{"key":"e_1_2_5_312_1","unstructured":"European Medicines Agency.Tremfya [Tremfya: EPAR \u2010 Product Information]. In.2017."},{"key":"e_1_2_5_313_1","unstructured":"European Medicines Agency.Skyrizi \u2010 EMEA\/H\/C\/004759 \u2010 IA\/0006. In.2019."},{"key":"e_1_2_5_314_1","unstructured":"European Medicines Agency.Stelara [INN\u2010Ustekinumab: EPAR \u2010 Product Information]. In.2009."},{"key":"e_1_2_5_315_1","unstructured":"European Medicines Agency.IlumetriTM (Tildrakizumab) Summary of product characteristics. In.2019."},{"key":"e_1_2_5_316_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.01.002"},{"key":"e_1_2_5_317_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13994"},{"key":"e_1_2_5_318_1","unstructured":"Van der KraaijGE.EADV Congress Poster FC02.06."},{"key":"e_1_2_5_319_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16980"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16926","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.16926","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T16:45:37Z","timestamp":1724431537000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.16926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":318,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1111\/jdv.16926"],"URL":"https:\/\/doi.org\/10.1111\/jdv.16926","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"2020-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}